On Wednesday, Shares of Southwest Airlines Co (NYSE:LUV), gained 0.18% to $33.92.
Southwest Airlines, is on a mission to hire an additional 650 Customer Service Representatives at call centers in Albuquerque, N.M.; Phoenix; and San Antonio. Southwest Airlines Customer Service Representatives provide the legendary Customer Service Southwest Airlines is known for while resolving Customer concerns, providing information, and assisting with reservations.
“A passion for assisting people is a key to success in Southwest’s Customer Service Representative role,” said Julie Weber, Vice President People. “We are looking for hardworking, fun-loving, and caring people who will give their all to assist connect our Customers to what’s important in their lives.”
Southwest Airlines Co. operates passenger airlines that provide planned air transportation services in the United States and near-international markets. As of December 31, 2014, it operated 665 Boeing 737 aircraft; and had 12 Boeing 717 aircraft.
Shares of Envision Healthcare Holdings Inc (NYSE:EVHC), inclined 0.32% to $40.25, during its last trading session.
Envision Healthcare Holdings, planned to release its second quarter and year-to-date operating results for the three months and six months ended June 30, 2015, after the securities markets close on Thursday, July 30, 2015, with a conference call to follow at 5 p.m. Eastern Time.
Envision Healthcare Holdings, Inc. provides physician-led, outsourced medical services to consumers, hospitals, healthcare systems, health plans, and government entities in the United States.
Finally, Axovant Sciences Ltd (NYSE:AXON), ended its last trade with 1.82% gain, and closed at $17.30.
Axovant Sciences Ltd., declared that the company will host an investor briefing on July 22 at 5:45 p.m. EDT following its presentation of RVT-101 clinical data at the Alzheimer’s Association International Conference 2015 (AAIC).
Axovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of therapeutics for the treatment of neurodegenerative disorders.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
